Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tick-borne anaplasmosis and myocarditis in eastern Ontario.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026

Same author

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients.

Journal of lipid research·2026

Same author

Being human: ableism, advocacy, and strengthening medicine.

Lancet (London, England)·2026

Same author

Letter to the editor: improving accessibility and disability inclusion in career transitions.

CJEM·2026

Same author

Report on the Joint Symposium of the Korean Society of CardioMetabolic Syndrome (KSCMS) and the Japanese Society of Hypertension (JSH) at the 8th Asia-Pacific CardioMetabolic Syndrome (APCMS) Congress in Seoul.

Hypertension research : official journal of the Japanese Society of Hypertension·2025

Same author

Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a comparative study of 2018-2019 and 2020-2021.

The Korean journal of internal medicine·2025

Search research articles

Related Experiment Videos

Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.

Seung Hwan Han¹, Michael J Quon, Kwang Kon Koh

¹Division of Cardiology, Gachon Medical School, Incheon, South Korea.

Current Opinion in Lipidology

|January 16, 2007

Summary

Shared factors like glucotoxicity, lipotoxicity, and inflammation link insulin resistance and endothelial dysfunction. Treatments targeting either condition can improve both metabolic and vascular health, benefiting cardiovascular disease patients.

Related Experiment Videos

Area of Science:

Cardiovascular Medicine
Metabolic Syndrome Research
Endothelial Function Studies

Background:

Endothelial dysfunction is a key factor in atherosclerosis and cardiovascular diseases.
Glucotoxicity, lipotoxicity, and inflammation independently contribute to endothelial dysfunction and insulin resistance.
These factors create a complex interplay between metabolic and vascular health.

Purpose of the Study:

To review the pathophysiological mechanisms linking endothelial dysfunction and insulin resistance.
To explore insights from therapeutic interventions that improve both metabolic and vascular function.
To understand the clustering of metabolic and cardiovascular disorders.

Main Methods:

Literature review of pathophysiological mechanisms.
Analysis of shared causal factors (glucotoxicity, lipotoxicity, inflammation).
Examination of therapeutic interventions and their effects.

Main Results:

Shared factors create reciprocal relationships between insulin resistance and endothelial dysfunction.
Metabolic abnormalities (hyperglycemia, dyslipidemia, etc.) contribute to endothelial dysfunction.
Diet, exercise, drugs, and insulin sensitizers improve both insulin sensitivity and vascular function.

Conclusions:

Reciprocal relationships between endothelial dysfunction and insulin resistance drive metabolic syndrome.
Targeting either endothelial dysfunction or insulin resistance can simultaneously improve both conditions.
Interventions offer a dual benefit for metabolic and vascular health.